2013
DOI: 10.1016/j.bjid.2013.05.004
|View full text |Cite
|
Sign up to set email alerts
|

A literature review on cardiovascular risk in human immunodeficiency virus-infected patients: implications for clinical management

Abstract: Physicians must weigh the cardiovascular risk against potential benefits when prescribing highly active antiretroviral therapy. Careful cardiac screening is warranted for patients who are being evaluated for, or who are receiving highly active antiretroviral therapy regimens, particularly for those with known underlying cardiovascular risk factors. A better understanding of the molecular mechanisms responsible for increased risk of cardiovascular diseases in human immunodeficiency virus-infected patients will … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
20
0

Year Published

2015
2015
2017
2017

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 15 publications
(20 citation statements)
references
References 56 publications
0
20
0
Order By: Relevance
“…4e8, 15,21,28e30 A collective influence of these tools on the vascular system is recognized, but the exact individual contribution requires appraisal. 35,36 Hence, although endovascular interventions can be performed in HIV-patients, the localized mechanical interventions are also subjected to these systemic HIV-related pathophysiological complexities. 3e7,14 Currently there are no structured guidelines advising on the respective roles of surgical and endovascular treatment for the management of vascular pathology in HIV patients.…”
Section: Discussionmentioning
confidence: 99%
“…4e8, 15,21,28e30 A collective influence of these tools on the vascular system is recognized, but the exact individual contribution requires appraisal. 35,36 Hence, although endovascular interventions can be performed in HIV-patients, the localized mechanical interventions are also subjected to these systemic HIV-related pathophysiological complexities. 3e7,14 Currently there are no structured guidelines advising on the respective roles of surgical and endovascular treatment for the management of vascular pathology in HIV patients.…”
Section: Discussionmentioning
confidence: 99%
“…If there is no additional risk, retest 3e6 months after the start of treatment and then annually. 11,19,20 (2) Electrocardiography: due to the increased risk of heart disease, a resting 12-lead electrocardiogram is recommended. 16 (3) BMD: the literature recommends that for all HIV-infected postmenopausal women and men aged > 50 years BMD should be tested and, if normal, the test should be repeated every 2e5 years.…”
Section: Hiv Disease Stages and Classificationmentioning
confidence: 99%
“…HIV treatment involves administration of antiretroviral drugs that suppress viral replication and increase immune function (Kavanagh et al, 2015). These drugs have greatly increased the life span of people living with HIV (PLWH), making them susceptible to chronic disease (Desai et al, 2015; Neto, Zwirtes, & Brites, 2013). Thus, adaptation of a healthy lifestyle that includes regular physical activity (PA) is important to long term health in PLWH.…”
Section: Introductionmentioning
confidence: 99%